Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

Validation of the "Metroticket" model in a cohort of patients transplanted for hepatocellular carcinoma in southern Brazil.

Machado A, Kiss G, Ernani L, Marroni C, Zanotelli ML, Cantisani G, Cerski CT, Coral G, Brandão A; Liver Transplantation Group.

Clin Transplant. 2015 Jun 28. doi: 10.1111/ctr.12583. [Epub ahead of print]

PMID:
26119109
2.

D-MELD does not predict post-liver transplantation survival: a single-center experience from Brazil.

Costabeber AM, Lionço LC, Marroni C, Zanotelli ML, Cantisani G, Brandão A.

Ann Hepatol. 2014 Nov-Dec;13(6):781-7.

3.

Acute kidney injury after liver transplantation: incidence and mortality.

Klaus F, Keitel da Silva C, Meinerz G, Carvalho LM, Goldani JC, Cantisani G, Zanotelli ML, Duro Garcia V, Keitel E.

Transplant Proc. 2014 Jul-Aug;46(6):1819-21. doi: 10.1016/j.transproceed.2014.05.053.

PMID:
25131045
4.

Is there an ideal cutoff for α-fetoprotein as an exclusion criterion for liver transplantation?

de Mattos AA, dos Santos Schraiber L, Zanotell ML, Cantisani G.

Liver Transpl. 2014 Oct;20(10):1284. doi: 10.1002/lt.23954. No abstract available.

PMID:
25044482
5.

Liver retransplantation in adults: a 20-year experience of one center in southern Brazil.

Costabeber AM, Granzotto M, Fleck Ade M Jr, Marroni CA, Zanotelli ML, Cantisani G, Lionço L, Musskopf MI, Brandão A; Liver Transplantation Group.

Ann Hepatol. 2013 Nov-Dec;12(6):942-51.

6.

Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.

Perrillo R, Buti M, Durand F, Charlton M, Gadano A, Cantisani G, Loong CC, Brown K, Hu W, Lopez-Talavera JC, Llamoso C.

Liver Transpl. 2013 Aug;19(8):887-95. doi: 10.1002/lt.23690.

7.

Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study.

Saliba F, De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Jonas S, Sudan D, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Dong G, Lopez PM, Fung J, Junge G; H2304 Study Group.

Am J Transplant. 2013 Jul;13(7):1734-45. doi: 10.1111/ajt.12280. Epub 2013 May 28.

8.

Impact of MELD score implementation on liver allocation: experience at a Brazilian center.

da Silva Machado AG, de Medeiros Fleck A Jr, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.

Ann Hepatol. 2013 May-Jun;12(3):440-7.

PMID:
23619261
9.

Impact of creatinine values on MELD scores in male and female candidates for liver transplantation.

Mariante-Neto G, Marroni CP, Fleck Junior AM, Marroni CA, Zanotelli ML, Cantisani G, Brandão AB.

Ann Hepatol. 2013 May-Jun;12(3):434-9.

PMID:
23619260
10.

MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.

Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC; Liver Transplantation Group.

Clin Transplant. 2012 Jul-Aug;26(4):E395-401. doi: 10.1111/j.1399-0012.2012.01688.x.

PMID:
22882694
11.

Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial.

Abdelmalek MF, Humar A, Stickel F, Andreone P, Pascher A, Barroso E, Neff GW, Ranjan D, Toselli LT, Gane EJ, Scarola J, Alberts RG, Maller ES, Lo CM; Sirolimus Liver Conversion Trial Study Group.

Am J Transplant. 2012 Mar;12(3):694-705. doi: 10.1111/j.1600-6143.2011.03919.x. Epub 2012 Jan 10.

12.

Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation.

Trunečka P, Boillot O, Seehofer D, Pinna AD, Fischer L, Ericzon BG, Troisi RI, Baccarani U, Ortiz de Urbina J, Wall W; Tacrolimus Prolonged Release Liver Study Group.

Am J Transplant. 2010 Oct;10(10):2313-23. doi: 10.1111/j.1600-6143.2010.03255.x. Epub 2010 Sep 14. Erratum in: Am J Transplant. 2010 Dec;10(12):2730.

13.

Survival benefit of liver transplantation and the effect of underlying liver disease.

Gleisner AL, Muñoz A, Brandao A, Marroni C, Zanotelli ML, Cantisani GG, Moreira LB, Choti MA, Pawlik TM.

Surgery. 2010 Mar;147(3):392-404. doi: 10.1016/j.surg.2009.10.006. Epub 2009 Dec 3.

PMID:
19962165
14.

MELD and other predictors of survival after liver transplantation.

Brandão A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G; Liver Transplantation Group.

Clin Transplant. 2009 Mar-Apr;23(2):220-7. doi: 10.1111/j.1399-0012.2008.00943.x. Epub 2009 Feb 5.

PMID:
19210688
15.

Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation.

Brandão A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G.

Clin Transplant. 2008 Sep-Oct;22(5):651-6. doi: 10.1111/j.1399-0012.2008.00860.x. Epub 2008 Jun 28.

PMID:
18549449
16.

12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.

Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.

Liver Transpl. 2006 Oct;12(10):1464-72.

17.

Impact of cytomegalovirus infection on long-term survival after orthotopic liver transplantation.

Hoppe L, Marroni CA, Bressane R, Lago L, Schiavo FL, Cigerza GC, Brandão AB, Zanotelli ML, Cantisani GP.

Transplant Proc. 2006 Jul-Aug;38(6):1924-5.

PMID:
16908325
18.

Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.

Hoppe L, Marroni CA, Bressane R, Lago L, Schiavo FL, Cigerza GC, Brandão AB, Zanotelli ML, Cantisani GP.

Transplant Proc. 2006 Jul-Aug;38(6):1922-3.

PMID:
16908324
19.

Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation.

Meine MH, Zanotelli ML, Neumann J, Kiss G, de Jesus Grezzana T, Leipnitz I, Schlindwein ES, Fleck A Jr, Gleisner AL, de Mello Brandão A, Marroni CA, Cantisani GP.

Transplant Proc. 2006 Jul-Aug;38(6):1872-5.

PMID:
16908310
20.

Liver glutathione depletion after preservation and reperfusion in human liver transplantation.

Grezzana Filho Tde J, Corso CO, Zanotelli ML, Marroni CA, Brandão AB, Schlindwein E, Leipnitz I, Meine MH, Fleck A Jr, Hoppen R, Kiss G, Cantisani GP.

Acta Cir Bras. 2006 Jul-Aug;21(4):223-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk